Naive and memory T cells induce different types of graft-versus-host disease

Journal of Immunology

Volumn 179, Issue 10, 2007, Pages 6547-6554

  Dutt, Suparna ^a   Tseng, Diane ^a   Ermann, Joerg ^a   George, Tracy I ^a   Yin, Ping Liu ^a   Davis, Corrine R ^a   Fathman, C Garrison ^a   Strober, Samuel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; INTERLEUKIN 2; L SELECTIN; ALLOANTIGEN; CCR7 PROTEIN, MOUSE; CD44 PROTEIN, MOUSE; HERMES ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; GRAFT VERSUS HOST REACTION; LIVER INJURY; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY T LYMPHOCYTE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ALLOTRANSPLANTATION; ANIMAL; ANTIBODY SPECIFICITY; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CHRONIC DISEASE; COMPARATIVE STUDY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INJURY; KINETICS; LIVER; LIVER DISEASE; MALE; PATHOLOGY; TIME;

ANIMALS; ANTIGENS, CD44; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; COLITIS; GRAFT VS HOST DISEASE; IMMUNOLOGIC MEMORY; ISOANTIGENS; KINETICS; L-SELECTIN; LIVER; LIVER DISEASES; MALE; MICE; MICE, INBRED BALB C; ORGAN SPECIFICITY; RECEPTORS, CCR7; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 38449089930     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.10.6547     Document Type: Article

References (29)

1. Ho, V. T., and R. J. Soiffer. 2001. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 98: 3192-3204.
2. + cells in class I different hosts. J. Exp. Med. 167: 556-569.
3. Korngold, R., and J. Sprent. 1990. T-cell subsets in graft-vs.-host disease. In Graft-vs.-Host Disease: Immunology, Pathophysiology, and Treatment S. J. Burakoff, H. J. Deeg, J. Ferrara, and K. Atkinson, eds. Marcel Dekker, New York, pp. 31-50.
4. + cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes. Bone Marrow Transplant. 35: 191-197.
5. + regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 196: 389-399.
6. + T cells do not induce graft-versus-host disease. J. Clin. Invest. 112: 101-108.
7. - memory T cells without graft-versus-host disease. Blood 103: 1534-1541.
8. Beilhack, A., S. Schulz, J. Baker, G. F. Beilhack, C. B. Wieland, E. I. Herman, E. M. Baker, Y. A. Cao, C. H. Contag, and R. S. Negrin. 2005. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood 106: 1113-1122.
9. Chen, B. J., D. Deoliveira, X. Cui, N. T. Le, J. Son, J. F. Whitesides, and N. J. Chao. 2007. Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse. Blood 109: 3115-3123.
10. Dutton, R. W., L. M. Bradley, and S. L. Swain. 1998. T cell memory. Annu. Rev. Immunol. 16: 201-223.
11. + memory T cells from the spleen lack MEL-14, the lymph node homing receptor. J. Immunol. 148: 324-331.
12. Budd, R. C., J. C. Cerottini, C. Horvath, C. Bron, T. Pedrazzini, R. C. Howe, and H. R. MacDonald. 1987. Distinction of virgin and memory T lymphocytes: stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J. Immunol. 138: 3120-3129.
13. Lerner, A., T. Yamada, and R. A. Miller. 1989. Pgp-1hi T lymphocytes accumulate with age in mice and respond poorly to concanavalin A. Eur. J. Immunol. 19: 977-982.
14. Min, B., G. Foucras, M. Meier-Schellersheim, and W. E. Paul. 2004. Spontaneous proliferation, a response of naive CD4 T cells determined by the diversity of the memory cell repertoire. Proc. Natl. Acad. Sci. USA 101: 3874-3879.
15. Zhang, Y., G. Joe, E. Hexner, J. Zhu, and S. G. Emerson. 2005. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease. J. Immunol. 174: 3051-3058.
16. Dutt, S., J. Ermann, D. Tseng, Y. P. Liu, T. I. George, C. G. Fathman, and S. Strober. 2005. L-selectin and β7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease. Blood 106: 4009-4015.
17. Kaplan, D. H., B. E. Anderson, J. M. McNiff, D. Jain, M. J. Shlomchik, and W. D. Shlomchik. 2004. Target antigens determine graft-versus-host disease phenotype. J. Immunol. 173: 5467-5475.
18. + T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells. J. Immunol. 167: 2087-2096.
19. Davies, M. D., and D. M. Parrott. 1981. Preparation and purification of lymphocytes from the epithelium and lamina propria of murine small intestine. Gut 22: 481-488.
20. + T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. J. Immunol. 172: 5456-5466.
21. Warnock, R. A., S. Askari, E. C. Butcher, and U. H. von Andrian. 1998. Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J. Exp. Med. 187: 205-216.
22. Baekkevold, E. S., T. Yamanaka, R. T. Palframan, H. S. Carlsen, F. P. Reinholt, U. H. von Andrian, P. Brandtzaeg, and G. Haraldsen. 2001. The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J. Exp. Med. 193: 1105-1112.
23. Cole, K. E., C. A. Strick, T. J. Paradis, K. T. Ogborne, M. Loetscher, R. P. Gladue, W. Lin, J. G. Boyd, B. Moser, D. E. Wood, et al. 1998. Interferon-inducible T cell α chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 187: 2009-2021.
24. Mapara, M. Y., C. Leng, Y. M. Kim, R. Bronson, A. Lokshin, A. Luster, and M. Sykes. 2006. Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR. Biol. Blood Marrow Transplant. 12: 623-634.
25. Gifford, G. E., and M. L. Lohmann-Matthes. 1987. γ Interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide. J. Natl. Cancer Inst. 78: 121-124.
26. Nestel, F. P., K. S. Price, T. A. Seemayer, and W. S. Lapp. 1992. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor α during graft-versus-host disease. J. Exp. Med. 175: 405-413.
27. Piguet, P. F., G. E. Grau, B. Allet, and P. Vassalli. 1987. Tumor necrosis factor/ cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J. Exp. Med. 166: 1280-1289.
28. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17: 138-146.
29. Wang, X., and T. Mosmann. 2001. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-γ, and can subsequently differentiate into IL-4- or IFN-γ-secreting cells. J. Exp. Med. 194: 1069-1080.